JGUA
OCDX

John G. Ullman & Associates’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

John G. Ullman & Associates’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-67,819
Closed -$1.27M – 173
2022
Q1 		$1.27M Sell
67,819
-113,513
-63% -$2.04M 0.18% 91
2021
Q4 		$3.88M Buy
181,332
+58,813
+48% +$1.16M 0.53% 50
2021
Q3 		$2.26M Buy
+122,519
New +$2.47M 0.31% 67

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

John G. Ullman & Associates's OCDX Position: Q2 2022 in Review

John G. Ullman & Associates sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 67,819 shares — an estimated $1.27M sold.

John G. Ullman & Associates first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $3.88M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • John G. Ullman & Associates reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • John G. Ullman & Associates sold 67,819 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.27M.
  • John G. Ullman & Associates first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
  • John G. Ullman & Associates's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.88M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on John G. Ullman & Associates's 13F filing for Q2 2022, filed 27 Jul 2022.